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Placental site trophoblastic tumor
ythema, anasarca and ascites. Her blood pressure was 140/90 mmHg.
A diagnosis of nephrotic syndrome (proteinuria with 24-h urine
specimen, N7 g/day) with normal kidney function was made (serum
creatinine, 50 μmol/L and blood urea nitrogen 7.4 mmol/L). Her hemo-
globin concentration was 117 g/L. Blood chemistry tests revealed levels
of total serum protein of 42.2 g/L (normal ranges, 60–85 g/L), albumin
26 g/L (normal ranges, 35–51 g/L), triglyceride 1.96 mmol/L (normal
ranges, 0.45–1.70 mmol/L), antistreptolysin-O 278 IU/ml, C4 comple-
ment 0.0716 g/L (normal ranges, 0.12–0.36 g/L). Tests for IgG type
titer of antinuclear antibody were 1:320 (normal ranges, b1:40), butIntroduction
PSTT usually follows a normal pregnancy or an abortion, and can be
cured by surgery and chemotherapy (Scully and Young, 1981). The
association of PSTT with kidney diseases is very rare. There is a single
recorded case of thrombotic microangiopathy (TMA) (Mazzucco
et al., 2011) and another of membranous glomerulonephritis (Batra
et al., 2007; Bologna et al., 1994). Only 2 other cases of PSTT and kidney
lesions have been reported. Both of these were described fully by
Young et al. as showing a distinctive glomerular lesion (Young et al.,
1985). We describe a case of lupus nephritis (LN) that occurred with
PSTT. Kidney biopsy showed diffuse global proliferative LN. This unusual
ﬁndings must be interpreted appropriately to achieve the correct
diagnosis.Case report
A 31-year-old female presented with amenorrhea lasting since full-
term normal delivery 19 months previously and generalized anasarca
for more than 1 month prior to presentation. One month before
admission she had developed progressive edema of her face, lowerand Gynecology, Peking Union
l Sciences, Shuai fu yuan 1#,
5124875.
c. This is an open access article undertests for C3 complement, anti-dsDNA antibody, rheumatoid factor, and
C-reactive protein were within normal ranges.
Because of the persistence of edema, hematuria and nephrotic pro-
teinuria, a kidney biopsywas performed to conﬁrm the diagnosis of glo-
merulopathy. Light microscopy revealed the renal cortex containing 30
glomeruli. Nonewas sclerotic. Therewere diffuse and global endothelial
and mesangium proliferation, widespread wireloops, thickened base-
ment membranes with focal and segmental subendothelial aggregates
and some duplication formation. The tubule epithelial cells were granu-
lar and showed vacuolar degeneration. The capillary loops were
even and thin. Therewas no evidence of pathologic changes in the inter-
stitium. Immunoﬂuorescence showed a full-house immunoﬂuores-
cence pattern, immunoglobulin G (++), IgM (++), IgA (+++),
C3 (+++), and C1q (+++) along the glomerular basement mem-
brane. Pathologic ﬁndings suggested diffuse global proliferative LN
(Class IV-G, active index 11 scores) (Fig. 1). Induction therapy using glu-
cocorticoids and cytotoxic drugs was started and lasted for almost
1 year. However, nephrotic syndrome (NS) didn't improve, as indicated
by the persistently elevated levels of the 24-h urine protein, which
ranged from 2.76 g to 4.81 g and renal function became poor with the
blood urea nitrogen elevation exceeding normal limits.
Because the patient's amenorrhea had persisted for more than
19 months with evidence of some uterine enlargement, serum human
chorionic gonadotropin (β-hCG) levels were checked, which was ele-
vated at 95.4 mIU/mL. Gynecological examination revealed a uterus of
about 14 weeks gestation. An abdominopelvic magnetic resonance im-
aging (MRI) scan showed uterine expansionwith a short T1 and long T2
signal. The uterine junction zone and myometrium were unclear,
and the diffuse vascular ﬂow void in myometrium and bilateral
parametrium showed signiﬁcant enhancement (Fig. 2). There was athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. (A) H&E staining shows increases in the number of glomerular cells, and visible thrombosis (arrow) (200×). (B) Periodic acid-Schiff staining shows a glomerulus with diffuse en-
dothelial and mesangium proliferation (arrow) (400×). (C) Masson staining shows thickened basement membranes with focal and segmental subendothelial aggregates (400×).
(D) Immunoﬂuorescence photomicrograph displaying diffuse deposition of C1q along basement membranes (200×).
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enlarged uterus of about 14 weeks gestational size and diffuse lesions
of the uterus by MRI scan, PSTT was highly suspected. But she was not
suitable for chemotherapywith poor kidney function. A total abdominal
hysterectomy with a bilateral salpingo-oophorectomy was performed.
Pathologic investigation showed typical features of PSTT deeply
inﬁltrating the whole layer of uterine corpus wall to the serosa
(Young et al., 1985). Sections were immunohistochemically evaluated
for β-hCG and human placental lactogen (HPL). These tumor cellsFig. 2. Pelvic MRI scan showing uterine cavity expansion. (A) Scan showing diffuse vascular ﬂshowed strong cytoplasmic positivity for HPL and negative for β-hCG.
Because of the patient's poor kidney function, she was not given
chemotherapy.
Two weeks later, a post-operative β-hCG reduced to 0.5 mIU/ml,
which is just within normal limits (WNL, b5 mIU/ml). The quantity of
the 24-h urine protein decreased to 0.40 g/L (normal ranges from 0 to
0.20 g/L). One month after operation the β-hCG level of this patient
wasWNLwith no proteinuria. Additional follow-up visits for the subse-
quent 15 months showed no evidence of recurrence or metastasis ofow void in myometrium and (B) bilateral parametrium with a signiﬁcant enhancement.
Table 1
Review of literature of cases of renal lesions associated with GTD.
Diagnosis of renal lesion GTD Author Renal biopsy performed No. Year
Thrombotic microangiopathy PSTT Mazzucco Mazzucco et al. (2011) Yes 1 2011
Membranous glomerulonephritis Invasive mole Yang Yang et al. (2010) Yes 1 2010
Membranous glomerulopathy PSTT Batra Batra et al. (2007) Yes 1 2007
Membranous glomerulonephritis Choriocarcinoma Altiparmak Altiparmak et al. (2003) Yes 1 2003
Membranoproliferative glomerulonephritis Hydatiform mole Komatsuda Komatsuda et al. (1992) Yes 1 1992
Occlusive eosinophilic deposit in capillary lumen PSTT Young Young et al. (1985) Yes 2 1985
GTD: Gestational trophoblastic disease, PSTT: Placental site trophoblastic tumor.
28 C. Xiao et al. / Gynecologic Oncology Reports 9 (2014) 26–28PSTT. The patient currently remains free of clinical symptoms of LN.
Tests for C3, C4, anti-dsDNA antibody, antinuclear antibody, rheumatoid
factor, and C-reactive protein were all within normal ranges.
Discussion
Gestational trophoblastic disease (GTD) is used to refer to a variety
of gynecological tumors arising from the trophoblastic cells, including
hydatidiform mole (complete or partial), choriocarcinoma, PSTT, and
ETT. The malignant transformation of trophoblastic tissue can cause a
paraneoplastic syndrome (Yang et al., 2010), which were thought to
be mediated by an immune response to malignant cells. Sometimes,
the clinical manifestations from the paraneoplastic syndrome are
noted prior to the diagnosis of malignancy. A number of different
types of glomerular disease, nephrotic or nephritic, may be associated
with malignancy (Jhaveri et al., 2013). Effective treatment of the
tumor generally leads to remission of the glomerular injury in these sit-
uations (Lefaucheur et al., 2006).
The association of renal lesions and GTD is very rare. Only a few case
reports have reported the association of NSwith GTD (Altiparmak et al.,
2003; Batra et al., 2007; Komatsuda et al., 1992; Mazzucco et al., 2011;
Yang et al., 2010; Young et al., 1985), which were summarized in
Table 1. In these cases, membranoproliferative glomerulonephritis
(Komatsuda et al., 1992) has been found to be associated with
hydatidiform mole, and membranous glomerulonephritis has been ob-
served with invasive mole and choriocarcinoma (Altiparmak et al.,
2003; Yang et al., 2010). For PSTT, there has been one reported case of
TMA and another of membranous glomerulonephritis (Batra et al.,
2007; Mazzucco et al., 2011). Only 2 other cases of PSTT and kidney le-
sions have been reported (Young et al., 1985). These glomerular lesions
have also been observed in the present patient, although similar fea-
tures may be observed under different circumstances. The present
case suggests a diagnosis of a variant of LN. This conclusion is supported
not only by light microscopy but also by immunohistochemistry ﬁnd-
ings. Conclusive evidence of LN comes from clinical and laboratory evi-
dence. According to diagnostic criteria for SLE by the American College
of Rheumatology in 1997, LN must be considered ﬁrst. The mechanism
may involve an immunologic process associated with LN, speciﬁcally
the presence of complement and immunoglobulin on immunoﬂuores-
cence and large subendothelial and smaller subepithelial andmesangial
deposits, as indicated by light microscopy. Because there are several
types of glomerulonephritis reported in association with epithelial and
hematologic neoplasia, a relationship with the PSTT may exist (Jhaveri
et al., 2013).
In the present case, LN was considered secondary to PSTT, because
this patient had presented with NS having amenorrhea for 19 monthswithout a clear etiology. She had no previous history of systemic lupus
erythematosus. She had received induction therapy with glucocorti-
coids and cytotoxic drugs for almost 1 year until PSTT was discovered
when the clinical symptoms of LN didn't resolve with medical therapy.
The fact that the clinical and biochemical features of nephrotic syn-
drome disappeared completely after the hysterectomy provides strong
evidence that LN was secondary to PSTT, although the pathogenesis of
this disease process is still unclear at this point.
In conclusion, this case provides a highlight of the correlation be-
tween LN and PSTT and also highlights the nephritic complications of
GTD.
Written informed consent was obtained from the patient for the
publication of this case report and the accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief of
this journal on request.
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